Consortium

University of Bern (UBERN) - Bern (CH)

The University of Bern offers top quality across the board: it enjoys special recognition in leading-edge disciplines, is reputed for the excellent quality of its teaching, offers a delightful setting, and a campus environment intimately linked to the social, economic and political life of the city.

The university’s comprehensive offering includes 8 faculties and some 160 institutes that date back to the XVIth century.

About the Theodor Kocher Institute

The Theodor Kocher Institute belongs to the faculties of Medicine, Natural Sciences and Veterinary Medicine of the University of Bern and is under the patronage of an interfaculty board. The institute was originally financed and built with an endowment from Theodor Kocher’s Nobel prize. Research at the Theodor Kocher Institute covers the topics of immune cell migration during immunosurvaillance and inflammation, vascular biology with a special focus on the blood-brain barrier and functions of innate immune cells in pulmonary disease with a special focus on the regulation of leukocyte proteases by serpins.

The institute is organized in individual research groups closely collaborating with each other. With its technical platform in live cell imaging using in vitro time lapse videomicroscopy, intravital epifluorescence microscopy and 2-photon microscopy the TKI is part of the Microscopy Imaging Center at the University of Bern. Senior researchers at the institute are mainly involved in teaching activities within the Problem Based Learning for medical students, the Master of Biomedical Sciences, Masters in Molecular Life Sciences Program and within the interfaculty Graduate School for Cellular and Biomedical Sciences.

IFOM-IEO Campus (IFOM) -  Milano (IT)

The IFOM-IEO Campus is a biomedical research centre based in Milan, created by the joint efforts of the FIRC Institute of Molecular Oncology Foundation (IFOM) and the Department of Experimental Oncology of the European Institute of Oncology (IEO), which have expanded and integrated their research activities on a common campus.

The fields of research range from molecular and cellular biology, genetics, functional genomics, proteomics, bioinformatics, system biology and bioethics. The research is supported by a core technology facility that offer cutting-edge technology (DNA arrays), bioinformatics, robotics, proteomics, structural biology and animal models.

Klinikum der Johann-Wolfgang Goethe-Universität (KGU) - Frankfurt (D)
Edinger Institute, Neurology

The medical school of the Johann-Wolfgang Goethe University, Frankfurt has a focus on cardiovascular and neurological research. The Institute of Neurology (Edinger-Institute), founded in 1883 by Ludwig Edinger (1855-1918), is the oldest institute for neuroscience in Germany.

More recently, the Edinger Institute together with other groups of the medical faculty of the Johann Wolfgang Goethe-University have become members of the excellence initiative „Excellence Cluster Cardio-Pulmonary System“ (ECCPS), underlining its focus on cutting edge vascular research with the focus on brain development, brain tumors, tumor angiogenesis and blood-brain barrier.

INSERM - Paris (FR)

INSERM (Institut National de la Santé Et de la Recherche Médicale) is a public institution with a scientific and technical vocation, under the dual auspices of the French Ministry of Health and the Ministry of Research. 

Institut Cochin – Biomedical Research Institute (INSERM U1016) - Paris (FR)

The Cochin Institute is the largest Inserm unit; it is also affiliated to the CNRS and is part of the Paris-Descartes University. The Cochin Institute currently consists of 33 teams in 4 scientific Departments together with a number of common facilities and technological platforms, on the same Campus as the Cochin Hospital, a major public hospital in Paris. The Cochin Institute provides technology platforms at a level of excellence, e.g. Cell Imaging , Proteomics, Transcriptomics, Transgenesis and Homologous recombination.

Leibniz-Institute for Molekulare Pharmakologie (FMP) - Berlin-Buch (D)

The research at the Leibniz-Institut für Molekulare Pharmakologie (FMP, legally represented by the Forschungsverbund Berlin e.V.) focuses on the structures, functions and interactions of proteins, on the identification of novel drugable targets, and on the development of new concepts for interfering pharmacologically with their functions. An interdisciplinary approach is crucial to this type of work, and a particular strength of the institute is the close interaction in the fields of chemistry and biology. This places the research activity of the institute at the forefront of drug development. The unique combination of technology platforms provides an ideal environment for research projects that strive to discover new biologically active molecules.

F. Hoffmann-La Roche Ltd, Basel  (Roche) - Basel (CH)

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80’000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan.
For more information: www.roche.com.

The JUSTBRAIN project will be carried out by Roche's CNS Group.

The focus of research in the Central Nervous System is on Alzheimer’s disease and depression, two diseases which affect millions of patients. Schizophrenia and anxiety are additional fields of scientific focus.

tp21 GmbH - Your technology partner for the 21st century - Berlin (D) 

is specialized in the design, planning and management of interdisciplinary research and development projects. We offer support in the successful implementation of your research project, in technology transfer and in the exploitation of research results. tp21 assists companies in the take up of new technologies via mapping solution scenarios, searching for know-how required, supervising feasibility studies and searching for co-financing opportunities.

Conception and realization of scientific catalogues and web based platforms, organization of exhibitions, congresses and training activities are additional services of tp21. The company's staff has a scientific, medical and engineering background with a long-standing experience in technology transfer and innovation management.